Cargando…
Biosafety of Mesoporous Silica Nanoparticles
Careful analysis of any new nanomedicine device or disposal should be undertaken to comprehensively characterize the new product before application, so that any unintended side effect is minimized. Because of the increasing number of nanotechnology-based drugs, we can anticipate that regulatory auth...
Autores principales: | Rascol, Estelle, Pisani, Cédric, Dorandeu, Christophe, Nyalosaso, Jeff L., Charnay, Clarence, Daurat, Morgane, Da Silva, Afitz, Devoisselle, Jean-Marie, Gaillard, Jean-Charles, Armengaud, Jean, Prat, Odette, Maynadier, Marie, Gary-Bobo, Magali, Garcia, Marcel, Chopineau, Joël, Guari, Yannick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352691/ https://www.ncbi.nlm.nih.gov/pubmed/31105244 http://dx.doi.org/10.3390/biomimetics3030022 |
Ejemplares similares
-
The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells
por: Pisani, Cédric, et al.
Publicado: (2017) -
Biological Fate of Fe(3)O(4) Core-Shell Mesoporous Silica Nanoparticles Depending on Particle Surface Chemistry
por: Rascol, Estelle, et al.
Publicado: (2017) -
Synergic effect of doxorubicin release and two-photon irradiation of Mn(2+)-doped Prussian blue nanoparticles on cancer therapy
por: Ali, Lamiaa M. A., et al.
Publicado: (2020) -
A Novel Approach to the Facile Growth and Organization of Photothermal Prussian Blue Nanocrystals on Different Surfaces
por: Ngo, Giang, et al.
Publicado: (2021) -
Large Pore Mesoporous Silica and Organosilica Nanoparticles for Pepstatin A Delivery in Breast Cancer Cells
por: Rahmani, Saher, et al.
Publicado: (2019)